Rifamycin use and gut microbial antibiotic resistance genes in cirrhosis: Results from a double-blind, placebo-controlled clinical trial

Jasmohan S. Bajaj, Brian C. Davis, Puneet Puri, Mary Leslie Gallagher, Andrew Fagan, Haley Obolewicz, Travis Mousel, Sai H. Boja, Masoumeh Sikaroodi, Patrick M. Gillevet

Open source

DOI: 10.1080/19490976.2026.2757339
Published: 2026-11-03
Container: Gut Microbes
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/19490976.2026.2757339,
  title = {Rifamycin use and gut microbial antibiotic resistance genes in cirrhosis: Results from a double-blind, placebo-controlled clinical trial},
  author = {Jasmohan S. Bajaj and Brian C. Davis and Puneet Puri and Mary Leslie Gallagher and Andrew Fagan and Haley Obolewicz and Travis Mousel and Sai H. Boja and Masoumeh Sikaroodi and Patrick M. Gillevet},
  year = {2026},
  journal = {Gut Microbes},
  doi = {10.1080/19490976.2026.2757339},
  url = {https://doi.org/10.1080/19490976.2026.2757339}
}

RIS

TY  - JOUR
TI  - Rifamycin use and gut microbial antibiotic resistance genes in cirrhosis: Results from a double-blind, placebo-controlled clinical trial
AU  - Jasmohan S. Bajaj
AU  - Brian C. Davis
AU  - Puneet Puri
AU  - Mary Leslie Gallagher
AU  - Andrew Fagan
AU  - Haley Obolewicz
AU  - Travis Mousel
AU  - Sai H. Boja
AU  - Masoumeh Sikaroodi
AU  - Patrick M. Gillevet
PY  - 2026
JO  - Gut Microbes
DO  - 10.1080/19490976.2026.2757339
UR  - https://doi.org/10.1080/19490976.2026.2757339
ER  -

APA

Bajaj, J. S., Davis, B. C., Puri, P., Gallagher, M. L., Fagan, A., Obolewicz, H., Mousel, T., Boja, S. H., Sikaroodi, M., & Gillevet, P. M. (2026). Rifamycin use and gut microbial antibiotic resistance genes in cirrhosis: Results from a double-blind, placebo-controlled clinical trial. Gut Microbes. https://doi.org/10.1080/19490976.2026.2757339

Source records

crossref · retrieved 2026-11-04T06:47:30.513Z